Pharming (PHAR) Change in Account Payables (2020 - 2025)
Pharming's (PHAR) quarterly Change in Account Payables came in at $17.8 million in Q4 2025, up 743.55% YoY from $2.1 million in Q4 2024, and up 743.55% on a QoQ basis from -$2.8 million in Q4 2024.
Pharming (PHAR) Change in Account Payables (2020 - 2025) Analysis & Trends
Pharming (PHAR) has 6 years of Change in Account Payables data on file, last reported at $17.8 million in Q4 2025.
- Quarterly Change in Account Payables rose 743.55% year-over-year to $17.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29.8 million (up 96.0% YoY) and the FY2025 annual result came in at $14.1 million, up 610.15% from the prior year.
- Change in Account Payables grew to $17.8 million in Q4 2025, from -$2.8 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $17.8 million in Q4 2025 to a low of -$4.0 million in Q4 2021.
- A 5-year average of $2.7 million and a median of -$985884.2 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables sank 54795.12% — and 2025, when it soared 743.55%.
- Tracing PHAR's Change in Account Payables over 5 years: stood at -$4.0 million in 2021, then surged by 58.94% to -$1.6 million in 2022, then soared by 595.62% to $8.2 million in 2023, then plunged by 133.96% to -$2.8 million in 2024, then surged by 743.55% to $17.8 million in 2025.
- The last three Change in Account Payables figures came in at $17.8 million (Q4 2025), -$2.8 million (Q4 2024), and $6.6 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.82 Mn |
| Dec 31, 2025 | 17.82 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Sep 30, 2024 | 6.56 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Dec 31, 2022 | -1.65 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Dec 31, 2021 | -4.01 Mn |
| Sep 30, 2021 | -985,884.20 |
| Sep 30, 2021 | -985,884.20 |
| Dec 31, 2020 | 7,324.24 |
| Dec 31, 2020 | 7,324.24 |